We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DMYS
3376
DELISTED
dMY Technology Group, Inc. VI
DMYS
-1,101,894
Closed -$11.1M
TWNI
3377
DELISTED
Tailwind International Acquisition Corp.
TWNI
-1,272,401
Closed -$12.8M
SJR
3378
DELISTED
Shaw Communications Inc.
SJR
-110,000
Closed -$3.17M
VLTA
3379
DELISTED
Volta Inc.
VLTA
-17,209
Closed -$6.2K
DCT
3380
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
-1,035,498
Closed -$12.5M
JMAC
3381
DELISTED
Maxpro Capital Acquisition Corp. Class A Common Stock
JMAC
-411,065
Closed -$4.27M
MSDAW
3382
CALL
DELISTED
MSD Acquisition Corp. Warrant
MSDAW
-221,591
Closed -$2.24M
MSDA
3383
DELISTED
MSD Acquisition Corp. Class A Ordinary Shares
MSDA
-1,107,955
Closed -$11.2M
TETCW
3384
CALL
DELISTED
Tech and Energy Transition Corporation Warrant
TETCW
-510,919
Closed -$5.12M
TETC
3385
DELISTED
Tech and Energy Transition Corporation Class A Common Stock
TETC
-1,820,517
Closed -$18.3M
ATCO
3386
DELISTED
Atlas Corp.
ATCO
-138,713
Closed -$2.13M
AIMC
3387
DELISTED
Altra Industrial Motion Corp
AIMC
-127,000
Closed -$7.59M
CRZNW
3388
CALL
DELISTED
Corazon Capital V838 Monoceros Corp Warrant
CRZNW
-249,996
Closed -$2.52M
CRZN
3389
DELISTED
Corazon Capital V838 Monoceros Corp Class A Ordinary Shares
CRZN
-849,988
Closed -$8.58M
NGC
3390
DELISTED
Northern Genesis Acquisition Corp. III
NGC
-135,411
Closed -$1.36M
RKTA
3391
DELISTED
Rocket Internet Growth Opportunities Corp.
RKTA
-838,016
Closed -$8.46M
SPKB
3392
DELISTED
Silver Spike Acquisition Corp II Class A Ordinary Shares
SPKB
-1,039,207
Closed -$10.5M
STRE
3393
DELISTED
Supernova Partners Acquisition Company III, Ltd.
STRE
-1,374,975
Closed -$13.9M
EVOP
3394
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
-30,539
Closed -$1.03M
LDHA
3395
DELISTED
LDH Growth Corp I Class A Ordinary Shares
LDHA
-511,261
Closed -$5.15M
LVRAW
3396
CALL
DELISTED
Levere Holdings Corp. Warrant
LVRAW
-383,331
Closed -$3.87M
LDHAW
3397
CALL
DELISTED
LDH Growth Corp I Warrant
LDHAW
-59,998
Closed -$604K
LVRA
3398
DELISTED
Levere Holdings Corp. Class A Ordinary Shares
LVRA
-1,334,992
Closed -$13.5M
DGNU
3399
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
-2,055,283
Closed -$20.2M
VPCB
3400
DELISTED
VPC Impact Acquisition Holdings II Class A ordinary shre
VPCB
-980,073
Closed -$9.91M

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.